Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
Description
Neutralising monoclonal antibody (mAb) is an important weapon in our arsenal for combating respiratory viral infections. However, the effectiveness of neutralising mAb has been impeded by the rapid emergence of mutant variants. Early administration
